We additionally confirmed these findings by assessing DTYMK mRNA expression in 40 pairs of HCC tumor and paracancerous tissue samples, which confirmed that DTYMK expression was increased 1.6-fold in HCC tumors relative to healthy tissues (Figure 1B). Here, DTYMK is linked to hepatocellular carcinoma.